Identification and prioritization of high-frequency biomarkers and therapeutic targets in gastric cancer trials.

BMC Cancer · 2025 · PMC12853831 · PMID 41454296

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Since 2020, the number of Phase I and I/II trials has shown a decreasing trend (Fig. 1 G).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.